Expression of cyclooxygenase isoforms in developing rat placenta, human term placenta, and BeWo human trophoblast model

Molecular Pharmaceutics

Volumn 2, Issue 6, 2005, Pages 481-490

  Xu, Yan ^a   Knipp, Gregory T ^a   Cook, Thomas J ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

Cyclooxygenase; Human; Metabolism; Placenta; Pregnancy; Rat; Trophoblast

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; ISOENZYME; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL STRAIN; CHILDBIRTH; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GESTATION PERIOD; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NONHUMAN; NUCLEOTIDE SEQUENCE; PLACENTA DEVELOPMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TROPHOBLAST; WESTERN BLOTTING;

ANIMALS; BASE SEQUENCE; CELL LINE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DNA PRIMERS; FEMALE; FETAL DEVELOPMENT; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MODELS, BIOLOGICAL; PLACENTA; PREGNANCY; PREGNANCY TRIMESTER, THIRD; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TROPHOBLASTS;

EID: 29544440857     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp0500519     Document Type: Article

References (50)

1. Tapiero, H.; Ba, G. N.; Couvreur, P.; Tew, K. D. Polyunsaturated fatty acids (PUFA) and eicosanoids in human health and pathologies. Biomed. Pharmacother. 2002, 56, 215-222.
2. Tanabe, T.; Tohnai, N. Cyclooxygenase isozymes and their gene structures and expression. Prostaglandins Other Lipid Mediators 2002, 68-69, 95-114.
3. Morita, I. Distinct functions of COX-1 and COX-2. Prostaglandins Other Lipid Mediators 2002, 68-69, 165-175.
4. Smith, W. L.; DeWitt, D. L.; Garavito, R. M. Cyclooxygenases: structural, cellular, and molecular biology. Annu. Rev. Biochem. 2000, 69, 145-182.
5. Challis, J. R. Prostaglandins and reproduction-what do knockouts really tell us? Nat. Med. 1997, 3, 1326-1327.
6. Kniss, D. A. Cyclooxygenases in reproductive medicine and biology. J. Soc. Gynecol. Invest. 1999, 6, 285-292.
7. Keelan, J. A.; Blumenstein, M.; Helliwell, R. J.; Sato, T. A.; Marvin, K. W.; Mitchell, M. D. Cytokines, prostaglandins and parturition-a review. Placenta 2003, 24 (Suppl. A), S33-S46.
8. Challis, J. R.; Sloboda, D. M.; Alfaidy, N.; Lye, S. J.; Gibb, W.; Patel, F. A.; Whittle, W. L. Newnham, J. P. Prostaglandins and mechanisms of preterm birth. Reproduction 2002, 124, 1-17.
9. Stanfield, K. M.; Bell, R. R.; Lisowski, A. R.; English, M. L.; Saldeen, S. S.; Khan, K. N. Expression of cyclooxygenase-2 in embryonic and fetal tissues during organogenesis and late pregnancy. Birth Defects Res., Part A 2003, 67, 54-58.
10. Skinner, K. A.; Challis, J. R. Changes in the synthesis and metabolism of prostaglandins by human fetal membranes and decidua at labor. Am. J. Obstet. Gynecol. 1985, 151, 519-523.
11. Teixeira, F. J.; Zakar, T.; Hirst, J. J.; Guo, F.; Sadowsky, D. W.; Machin, G.; Demianczuk, N.; Resch, B.; Olson, D. M. Prostaglandin endoperoxide-H synthase (PGHS) activity and immunoreactive PGHS-1 and PGHS-2 levels in human amnion throughout gestation, at term, and during labor. J. Clin. Endocrinol. Metab. 1994, 78, 1396-1402.
12. Gibb, W.; Sun, M. Localization of prostaglandin H synthase type 2 protein and mRNA in term human fetal membranes and deciduas. J. Endocrinol. 1996, 150, 497-503.
13. Freed, K. A.; Aitken, M. A.; Brennecke, S. P.; Rice, G. E. Prostaglandin G/H synthase-1 messenger RNA relative abundance in human amnion, choriodecidua and placenta before, during and after spontaneous-onset labour at term. Gynecol. Obstet. Invest. 1995, 39, 73-78.
14. Macchia, L.; Di Paola, R.; Guerrese, M. C.; Chiechi, L. M.; Tursi, A.; Caiaffa, M. F.; Haeggstrom, J. Z. Expression of prostaglandin endoperoxide H synthase 1 and 2 in human placenta at term. Biochem. Biophys. Res. Commun. 1997, 233, 496-501.
15. Wetzka, B.; Nusing, R.; Charnock-Jones, D. S.; Schafer, W.; Zahradnik, H. P.; Smith, S. K. Cyclooxygenase-1 and -2 in human placenta and placental bed after normal and pre-eclamptic pregnancies. Hum. Reprod. 1997, 12, 2313-2320.
16. Mamdani, M.; Juurlink, D. N.; Lee, D. S.; Rochon, P. A.; Kopp, A.; Naglie, G.; Austin, P. C.; Laupacis, A.; Stukel, T. A. Cyclooxygenase-2 inhibitors versus non-selective non-steroidal anti-inflammatory drugs and congestive heart failure outcomes in elderly patients: a population-based cohort study. Lancet 2004, 363, 1751-1756.
17. Mendonca, L. L.; Khamashta, M. A.; Nelson-Piercy, C.; Hunt, B. J.; Hughes, G. R. Non-steroidal anti-inflammatory drugs as a possible cause for reversible infertility. Rheumatology (Oxford) 2000, 39, 880-882.
18. Smith, G.; Roberts, R.; Hall, C.; Nuki, G. Reversible ovulatory failure associated with the development of luteinized unruptured follicles in women with inflammatory arthritis taking non-steroidal anti-inflammatory drugs. Br. J. Rheumatol. 1996, 35, 458-462.
19. Akil, M.; Amos, R. S.; Stewart, P. Infertility may sometimes be associated with NSAID consumption. Br. J. Rheumatol. 1996, 35, 76-78.
20. Ojala, R.; Ikonen, S.; Tammela, O. Perinatal indomethacin treatment and neonatal complications in preterm infants. Eur. J. Pediatr. 2000, 159, 153-155.
21. Macones, G. A.; Marder, S. J.; Clothier, B.; Stamilio, D. M. The controversy surrounding indomethacin for tocolysis. Am. J. Obstet. Gynecol. 2001, 184, 264-272.
22. Soares, M. J. Molecular Mechanisms of Placental Development. In Placental Function and Fetal Nutrition; Nestlé Nutrition Workshop Series, Vol. 39; Battaglia, F. C., Ed.; Nestec Ltd. Vevey/Lippincott-Raven Publishers: Philadelphia, PA, 1997; pp 31-45.
23. Liu, F.; Soares, M. J.; Audus, K. L. Permeability properties of monolayers of the human trophoblast cell line BeWo. Am. J. Physiol. 1997, 273, C1596-C1604.
24. Ushigome, F.; Takanaga, H.; Matsuo, H.; Tsukimori, K.; Nakano, H.; Ohtani, H.; Sawada Y. Uptake mechanism of valproic acid in human placental choriocarcinoma cell line (BeWo). Eur. J. Pharmacol 2001, 417, 169-176.
25. Huang, S. N.; Swaan, P. W. Riboflavin uptake in human trophoblast-derived BeWo cell monolayers: cellular translocation and regulatory mechanisms. J. Pharmacol. Exp. Ther. 2001, 298, 264-271.
26. Ampasavate, C.; Chandorkar, G. A.; Vande Velde, D. G.; Stobaugh, J. F.; Audus, K. L. Transport and metabolism of opioid peptides across BeWo cells, an in vitro model of the placental barrier. Int. J. Pharm. 2002, 233, 85-98.
27. Rytting, E.; Audus, K. L. Novel organic cation transporter 2-mediated carnitine uptake in placental choriocarcinoma (BeWo) cells. J. Pharmacol. Exp. Ther. 2005, 312, 192-198.
28. Soares, M. J. Developmental changes in the intraplacental distribution of placental lactogen and alkaline phosphatase in the rat. J. Reprod. Fertil. 1987, 79, 93-98.
29. Pattillo, R. A.; Gey, G. O. The establishment of a cell line of human hormone-synthesizing trophoblastic cells in vitro. Cancer Res. 1968, 28, 1231-1236.
30. Xu, Y.; Knipp, G. T.; Cook, T. J. Expression of CYP4A isoforms in developing rat placenta and trophoblast cell models. Placenta 2005, 26, 218-225.
31. Xu, Y.; Cook, T. J.; Knipp, G. T. Effects of di-(2-ethylhexyl)-phthalate (DEHP) and its metabolites on fatty acid homeostasis regulating proteins in rat placental HRP-1 trophoblast cells. Toxicol. Sci. 2005, 84, 287-300.
32. Loftin, C. D.; Tiano, H. F.; Langenbach, R. Phenotypes of the COX-deficient mice indicate physiological and pathophysiological roles for COX-1 and COX-2. Prostaglandins Other Lipid Mediators 2002, 68-69, 177-185.
33. Gross, G. A.; Imamura, T.; Luedke, C.; Vogt, S. K.; Olson, L. M.; Nelson, D. M.; Sadovsky, Y.; Muglia, L. J. Opposing actions of prostaglandins and oxytocin determine the onset of murine labor. Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 11875-11879.
34. Johnston, P. C.; Greer, I. A.; Brooks, A. N. The transfer of prostaglandin E2 across ovine fetal membranes in vivo. J. Soc. Gynecol. Invest. 1996, 3, 303-308.
35. Bennett, P. R.; Chamberlain, G. V.; Patel, L.; Elder, M. G.; Myatt, L. Mechanisms of parturition: the transfer of prostaglandin E2 and 5-hydroxyeicosatetraenoic acid across fetal membranes. Am. J. Obstet. Gynecol. 1990, 162, 683-687.
36. Nakla, S.; Skinner, K.; Mitchell, B. F.; Challis, J. R. Changes in prostaglandin transfer across human fetal membranes obtained after spontaneous labor. Am. J. Obstet. Gynecol. 1986, 155, 1337-1341.
37. Egan, R. W.; Paxton, J.; Kuehl, F. A., Jr. Mechanism for irreversible self-deactivation of prostaglandin synthetase. J. Biol. Chem. 1976, 251, 7329-7335.
38. Johansen, B.; Rakkestad, K.; Balboa, M. A.; Dennis, E. A. Expression of cytosolic and secreted forms of phospholipase A(2) and cyclooxygenases in human placenta, fetal membranes, and chorionic cell lines. Prostaglandins Other Lipid Mediators 2000, 60, 119-125.
39. Allport, V. C.; Pieber, D.; Slater, D. M.; Newton, R.; White, J. O.; Bennett, P. R. Human labour is associated with nuclear factor-kappaB activity which mediates cyclo-oxygenase-2 expression and is involved with the "functional progesterone withdrawal". Mol. Hum. Reprod. 2001, 7, 581-586.
40. Yan, X.; Wu, X. C.; Sun, M.; Tsang, B. K.; Gibb, W. Nuclear factor kappa B activation and regulation of cyclooxygenase type-2 expression in human amnion mesenchymal cells by interleukin-1beta. Biol. Reprod. 2002, 66, 1667-1671.
41. Perkins, D. J.; Kniss, D. A. Tumor necrosis factor-alpha promotes sustained cyclooxygenase-2 expression: attenuation by dexamethasone and NSAIDs. Prostaglandin 1997, 54, 727-743.
42. Imseis, H. M.; Zimmerman, P. D.; Samuels, P.; Kniss, D. A. Tumour necrosis factor-alpha induces cyclo-oxygenase-2 gene expression in first trimester trophoblasts: suppression by glucocorticoids and NSAIDs. Placenta 1997, 18, 521-526.
43. Lemberger, T.; Desvergne, B.; Wahli, W. Peroxisome proliferator-activated receptors: a nuclear receptor signaling pathway in lipid physiology. Annu. Rev. Cell Dev. Biol. 1996, 12, 335-363.
44. Staels, B.; Koenig, W.; Habib, A.; Merval, R.; Lebret, M.; Torra, I. P.; Delerive, P.; Fadel, A.; Chinetti, G.; Fruchart, J. C.; Najib, J.; Maclouf, J.; Tedgui, A. Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators. Nature 1998, 393, 790-793.
45. Inoue, H.; Tanabe, T.; Umesono, K. Feedback control of cyclooxygenase-2 expression through PPARgamma. J. Biol. Chem. 2000, 275, 28028-28032.
46. Subbaramaiah, K.; Lin, D. T.; Hart, J. C.; Dannenberg, A. J. Peroxisome proliferator-activated receptor gamma ligands suppress the transcriptional activation of cyclooxygenase-2. Evidence for involvement of activator protein-1 and CREB-binding protein/p300. J. Biol. Chem. 2001, 276, 12440-12448.
47. Dunn-Albanese, L. R.; Ackerman, W. E., 4th; Xie, Y.; Iams, J. D.; Kniss, D. A. Reciprocal expression of peroxisome proliferator-activated receptor-gamma and cyclooxygenase-2 in human term parturition. Am. J. Obstet. Gynecol. 2004, 190, 809-816.
48. Chan, V. S. A mechanistic perspective on the specificity and extent of COX-2 inhibition in pregnancy. Drug Saf. 2004, 27, 421-426.
49. Loudon, J. A.; Groom, K. M.; Bennett, P. R. Prostaglandin inhibitors in preterm labour. Best Pract. Res., Clin. Obstet. Gynaecol. 2003, 17, 731-744.
50. Onn, A.; Tseng, J. E.; Herbst, R. S. Thalidomide, cyclooxygnase-2, and angiogenesis. Clin. Cancer Res. 2001, 7, 3311-3313.